MetaCap

Retension Pharmaceuticals, Inc. - (RTSN)

NASDAQ: RTSNHealthcareBiotechnologyUSD

11.32+0.79 (+7.50%)

At close: Oct 12, 4:00 PM ET · Delayed 15 min

After hours: 11.30 -0.18%

RTSN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$89.22M
EPS (TTM)
-$2.61
52-week range
9.66 – 11.79
Day range
10.16 – 11.79
Volume / Avg
173.68K / 789.20K
Beta
—

52-week range

$9.66$11.79

RTSN stock today

Retension Pharmaceuticals - (RTSN) closed at $11.32 on Oct 12, up 7.50% (+$0.79), versus the S&P 500's 0.06% decline. Trading was light, with 173.68K shares changing hands, about 22% of the average daily volume. Shares are 4.0% below their 52-week high of $11.79 and 17.2% above the 52-week low of $9.66, in the middle of the past year's range.

Retension Pharmaceuticals - has posted a net loss over the last twelve months (EPS of -$2.61), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Retension Pharmaceuticals -

Company profile

Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. It offers RTN -001, an oral, small molecule phosphodiesterase -5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling.

Industry
Biotechnology
Headquarters
Falls Church, VA
Employees
12

Retension Pharmaceuticals - peers

Healthcare sector
RTSN peer companies
CompanyPrice% ChgMarket capCompare
ACOGAlpha Cognition Inc.8.84-2.21%$192.52Mvs RTSN
TRXBTRex Bio, Inc. -14.03+0.21%$385.06Mvs RTSN

Indexes, lists and sector

Retension Pharmaceuticals - stock FAQ

What is Retension Pharmaceuticals -'s stock price today?

RTSN last traded at $11.32 as of Oct 12, 4:00 PM EDT, up 7.50% on the day. Prices are delayed at least 15 minutes.

What is the RTSN 52-week high?

The 52-week high for RTSN is $11.79 and the 52-week low is $9.66. The stock is currently 4.0% below its high.

Compare RTSN